Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Zuli Zhou"'
Publikováno v:
Frontiers in Surgery, Vol 9 (2022)
BackgroundThis study aims to investigate the clinical efficacy of video-assisted thoracic surgery (VATS) in treating mediastinal mature teratoma (MMT) and explore the clinical factors that increase the difficulties associated with VATS.MethodWe retro
Externí odkaz:
https://doaj.org/article/65adcce762064fcfaacfaac357f26096
Autor:
Lu Xie, Jie Xu, Xiaowei Li, Zuli Zhou, Hongqing Zhuang, Xin Sun, Kuisheng Liu, Xingyu Liu, Kunkun Sun, Yiming Wu, Jin Gu, Wei Guo
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-12 (2021)
Abstract Background Complete surgical remission (CSR) is the best predictor of overall survival (OS) for patients with metastatic osteosarcoma. However, metastasectomy has not been widely implemented in China in the last decade due to various factors
Externí odkaz:
https://doaj.org/article/1bc95363516140e69017feaa31da4a8b
Publikováno v:
BMC Surgery, Vol 21, Iss 1, Pp 1-5 (2021)
Abstract Background Neurofibroma of the esophagus, originated from the nerve sheath cells and fibroblasts of the esophageal submucosal plexus or the intestinal intermuscular plexus, is a very rare mesenchymal tumor. Most of the cases are treated by s
Externí odkaz:
https://doaj.org/article/86a2521cfe9042768cf46f1cf501c681
Autor:
Desong YANG, Yun LI, Jun LIU, Guanchao JIANG, Jianfeng LI, Hui ZHAO, Fan YANG, Yanguo LIU, Zuli ZHOU, Liang BU, Jun WANG
Publikováno v:
Chinese Journal of Lung Cancer, Vol 13, Iss 6, Pp 607-611 (2010)
Background and objective Solitary pulmonary nodules (SPN) is a knotty problem in clinical work. The clinical manifestation and pathological features of SPN in sizes may be obviously different. The aim of this study is to analyze the relationship betw
Externí odkaz:
https://doaj.org/article/c224a0c340fc44daa4231ff51e9c9cc6
Publikováno v:
Chinese Journal of Lung Cancer, Vol 11, Iss 5, Pp 640-645 (2008)
Externí odkaz:
https://doaj.org/article/bf83f42b4d9e4c01958611d548476559
Autor:
Hui ZHAO, Jun WANG, Jun LIU, Jianfeng LI, Guanchao JIANG, Yun LI, Fan YANG, Yanguo LIU, Zuli ZHOU
Publikováno v:
Chinese Journal of Lung Cancer, Vol 11, Iss 5, Pp 672-674 (2008)
Background and objective To determine the value of mediastinoscopy in the mediastinal staging of lung cancer with clinical N2 disease. Methods We retrospectively reviewed 87 patients received mediastinoscopy for known or suspected lung cancer, includ
Externí odkaz:
https://doaj.org/article/42437a945f534bc2a5235d7243a60ab3
Publikováno v:
Diseases of the Esophagus. 35
Chylothorax is a serious complication after esophagectomy and an important reason for reoperation and prolonged hospital stay. A clear localization of thoracic ducts (TDs) and the potential leakage site is an ideal strategy to prevent postoperative c
Autor:
Feng, Yang, Jian, Gao, Sida, Cheng, Hao, Li, Kunshan, He, Jian, Zhou, Kezhong, Chen, Zhenfan, Wang, Fan, Yang, Zeyu, Zhang, Jianfeng, Li, Zuli, Zhou, Chongwei, Chi, Yun, Li, Jun, Wang
Publikováno v:
Diseases of the Esophagus. 36
Summary Chylothorax is a serious complication after esophagectomy and there are unmet needs for new intraoperative navigation tools to reduce its incidence. The aim of this study is to explore the feasibility and effectiveness of near-infrared fluore
Background: To explore the different metastatic patterns between esophageal squamous-cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC).Methods: For this propensity-matched analysis, we used data from the latest iteration of the Surveillance,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e622dfb8e5de25d21b2e2eece99b6fc
https://doi.org/10.21203/rs.3.rs-499176/v1
https://doi.org/10.21203/rs.3.rs-499176/v1
Autor:
Lu Xie, Wei Guo, Kunkun Sun, Xin Liang, Xiaowei Li, Hongqing Zhuang, Xin Sun, Jie Xu, Jin Gu, Kuisheng Liu, Zuli Zhou, Yiming Wu
Publikováno v:
Oncology Letters
For osteosarcoma that progresses following first-line chemotherapy, prognosis remains poor although anti-angiogenesis tyrosine kinase inhibitors (TKIs) have been verified to prolong progression-free survival. Apatinib has led to positive responses in